Multiple Sclerosis Agents

Random Miscellaneous Quiz

Can you name the Multiple Sclerosis Agents?

Quiz not verified by Sporcle

How to Play
Duloxetine class
MOA: Purine analog
MOA: Antimetabolite and antifolate
MOA: Immunomodulator/antineoplastic
SE: Inj site rxn w/ high doses, flu-like s/s (responds well to naproxen), monitor liver fx, may develop neutralizing Ab, may increase depression.
Methylprednisone class
Glatiramer acetate class
MOA: Potassium channel blocker. Possibly increases conduction in demyelinated axons
Tizanidine class
Prednisone class
Use: For pts who do not respond to corticosteroids during acute attacks
Daclizumab class
MOA: Immune modulator, exact mechanism not known.
Methotrexate class
Bupropion class
MOA: Synthetic form of myelin basic PRO copolymer 1. Binds to MHC molecules. Competes w/ myelin antigens for presentation to T cells.
Dose: SC injection every other day
Cyclophosphamide class
Off line agent used in the treatment of acute attacks
Second line agent given IV monthy
Plasmapheresis class
Excreted by kidney: contraindicated in moderate to severe renal failure
Use: pain and paroxysmal disorders
Modafinil class
Second line agent: RRMS, SPMS, Progressive Relapsing MS
MOA: Monoclonal Ab. Shows functional improvement not just slowing of decline
IFN beta 1-a (Avonex) class
SE: Seizures at higher than recommended doses (contraindicated in pts with a hx of seizure)
MOA: alkylating agent
Mitoxantrone class
Dalfampridine class
Dose: Oral. In extreme cases intrathecal
Dose: 1250 mg/day PO for 3-5 days
Second line agent for RRMS that produces reduction in progression of disabilty
Alemtizumab class
Tricyclic class
Methylphenidate class
SE: Localized inj site reactions. Self-limited (15-20 min) acute rxn resembling a panic attack (palpitations, dyspnea, flushing) -- not an indication to stop tx
MOA: Anti-organ rejection drug
Carbamazepine class
IFN beta 1-b (Betaseron) class
Dose: Oral daily (first PO MS drug)
Rituximab class
IFN beta 1-a (Rebif) class
Use: Fatigue
Use: Fatigue, cognitive impairment (long acting agent)
Use: Depression. Also helps with fatigue
Second line agent: RRMS. Reduced relapses & progression of disability
SE: Thyroid disorders, ITP (with fatal brain hemorrhage), infections.
Dose: 1 gram/day IV for 3-5 days
Dose: IV infusion every 3 months
Second line agent MOA: monoclonal Ab
Mycophenolate class
Venlafaxine class
First line drugs for disease modification
Baclofen class
Use: Depression. Also helps with pain
MOA: Sphingosine 1-phosphate receptor modulator. Sequesters lymphocytes.
Dose: SC injection 2-3 times weekly
Gabapentin class
SE: Risk of progressive multifocal leukoencephalopathy. Rare fatal viral (polymyxoma JC virus) reactivation infxn affecting white matter in immunosuppressed (only a risk to pts w/
Natalizumab class
Fingolimod class
SE: HR reduction of 10-20 bpm, occasionally bradyarrhythmias or AV block -- screen for cardiac dz (6 hr monitoring w/ first dose). Macular edema in 1% (reversible). Check varicella
Use: treatment of spasticity
Axathioprine class
Dose: IM weekly
First line RRMS agent injected SC daily

Friend Scores

  Player Best Score Plays Last Played
You You haven't played this game yet.

You Might Also Like...


Created Oct 18, 2011ReportNominate
Tags:agent, multiple